SR ONE CAPITAL MANAGEMENT, LLC has filed 15 insider transactions across 2 companies since May 2023.
Most recent transaction: a purchase of 63158 shares of Zenas BioPharma, Inc. ($ZBIO) on October 09, 2025.
Activity breakdown: 5 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 9, 2025 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 63158 | $19.00 | 5,037,854.0000 | 42,159,340 | 1.27% | 0.15% |
| Oct. 9, 2025 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 63157 | $19.00 | 5,037,854.0000 | 42,159,340 | 1.27% | 0.15% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 501796 | $0.00 | 3,558,597.0000 | 1,567,269 | 16.42% | 32.02% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 1352942 | $17.00 | 4,911,539.0000 | 1,567,269 | 38.02% | 86.33% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 669061 | $0.00 | 4,470,363.0000 | 1,567,269 | 17.60% | 42.69% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 441176 | $17.00 | 4,911,539.0000 | 1,567,269 | 9.87% | 28.15% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C Convertible Preferred Stock | 13071439 | $0.00 | 0.0000 | 1,567,269 | 100.00% | 100.00% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C Convertible Preferred Stock | 4357146 | $0.00 | 0.0000 | 1,567,269 | 100.00% | 100.00% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Series C Convertible Preferred Stock | 5809528 | $0.00 | 0.0000 | 1,567,269 | 100.00% | 100.00% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | C | Common Stock | 1505388 | $0.00 | 4,470,363.0000 | 1,567,269 | 50.77% | 96.05% |
| Sept. 16, 2024 | Zenas BioPharma, Inc. | $ZBIO | SR ONE CAPITAL MANAGEMENT, LLC | Not found | P | Common Stock | 441176 | $17.00 | 4,911,539.0000 | 1,567,269 | 9.87% | 28.15% |
| May 11, 2023 | Arcellx, Inc. | $ACLX | SR ONE CAPITAL MANAGEMENT, LLC | TenPercentOwner | S | Common Stock | 631932 | $45.00 | 4,493,659.0000 | 0 | 12.33% | 0.00% |
| May 11, 2023 | Arcellx, Inc. | $ACLX | SR ONE CAPITAL MANAGEMENT, LLC | TenPercentOwner | S | Common Stock | 370612 | $45.00 | 4,490,978.0000 | 0 | 7.62% | 0.00% |
| May 11, 2023 | Arcellx, Inc. | $ACLX | SR ONE CAPITAL MANAGEMENT, LLC | TenPercentOwner | S | Common Stock | 6485 | $46.15 | 4,487,174.0000 | 0 | 0.14% | 0.00% |
| May 11, 2023 | Arcellx, Inc. | $ACLX | SR ONE CAPITAL MANAGEMENT, LLC | TenPercentOwner | S | Common Stock | 3804 | $46.15 | 4,487,174.0000 | 0 | 0.08% | 0.00% |